These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9015390)
1. Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with "irreversible" NO synthase inhibitors. Wolff DJ; Lubeskie A; Li C Arch Biochem Biophys; 1997 Feb; 338(1):73-82. PubMed ID: 9015390 [TBL] [Abstract][Full Text] [Related]
2. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells. Cooper GR; Barr A; Wolff DJ Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine. Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas. Wolff DJ; Gauld DS; Neulander MJ; Southan G J Pharmacol Exp Ther; 1997 Oct; 283(1):265-73. PubMed ID: 9336332 [TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Wolff DJ; Lubeskie A Arch Biochem Biophys; 1995 Jan; 316(1):290-301. PubMed ID: 7530937 [TBL] [Abstract][Full Text] [Related]
6. Effect of nitric oxide synthase inhibitors on lipid peroxide formation in liver caused by endotoxin challenge. Sakaguchi S; Furusawa S; Yokota K; Sasaki K; Takayanagi M; Takayanagi Y Pharmacol Toxicol; 2000 Apr; 86(4):162-8. PubMed ID: 10815749 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide synthase isoforms by porphyrins. Wolff DJ; Naddelman RA; Lubeskie A; Saks DA Arch Biochem Biophys; 1996 Sep; 333(1):27-34. PubMed ID: 8806750 [TBL] [Abstract][Full Text] [Related]
8. Arginine metabolism in keratinocytes and macrophages during nitric oxide biosynthesis: multiple modes of action of nitric oxide synthase inhibitors. DeGeorge GL; Heck DE; Laskin JD Biochem Pharmacol; 1997 Jul; 54(1):103-12. PubMed ID: 9296356 [TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282 [TBL] [Abstract][Full Text] [Related]
10. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. Zhang GL; Wang YH; Teng HL; Lin ZB World J Gastroenterol; 2001 Jun; 7(3):331-4. PubMed ID: 11819785 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine. Wolff DJ; Lubeskie A Arch Biochem Biophys; 1996 Jan; 325(2):227-34. PubMed ID: 8561501 [TBL] [Abstract][Full Text] [Related]
12. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability. Albakri QA; Stuehr DJ J Biol Chem; 1996 Mar; 271(10):5414-21. PubMed ID: 8621396 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine. Bryk R; Wolff DJ Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta. Joly GA; Narayanan K; Griffith OW; Kilbourn RG Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462 [TBL] [Abstract][Full Text] [Related]
15. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. Daghigh F; Borghaei RC; Thornton RD; Bee JH J Periodontol; 2002 Apr; 73(4):392-400. PubMed ID: 11990440 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-inhibitory effect of aminoguanidine on renal function in rats. Waz WR; Van Liew JB; Feld LG Kidney Blood Press Res; 1997; 20(4):211-7. PubMed ID: 9398025 [TBL] [Abstract][Full Text] [Related]
17. Expression of citrulline-nitric oxide cycle in lipopolysaccharide and cytokine-stimulated rat astroglioma C6 cells. Zhang WY; Takiguchi M; Koshiyama Y; Gotoh T; Nagasaki A; Iwase K; Yamamoto K; Takeshima H; Negi A; Mori M Brain Res; 1999 Dec; 849(1-2):78-84. PubMed ID: 10592289 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine. Weisz A; Cicatiello L; Esumi H Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):209-15. PubMed ID: 8645207 [TBL] [Abstract][Full Text] [Related]
19. Nitric oxide participation in the fungicidal mechanism of gamma interferon-activated murine macrophages against Paracoccidioides brasiliensis conidia. Gonzalez A; de Gregori W; Velez D; Restrepo A; Cano LE Infect Immun; 2000 May; 68(5):2546-52. PubMed ID: 10768942 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]